Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
111M
-
Number of holders
-
980
-
Total 13F shares, excl. options
-
107M
-
Shares change
-
+5.45M
-
Total reported value, excl. options
-
$19.3B
-
Value change
-
+$993M
-
Put/Call ratio
-
1.29
-
Number of buys
-
471
-
Number of sells
-
-406
-
Price
-
$179.63
Significant Holders of QUEST DIAGNOSTICS INC - COMMON STOCK (DGX) as of Q2 2025
1,092 filings reported holding DGX - QUEST DIAGNOSTICS INC - COMMON STOCK as of Q2 2025.
QUEST DIAGNOSTICS INC - COMMON STOCK (DGX) has 980 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 107M shares
of 111M outstanding shares and own 96.71% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (14.2M shares), BlackRock, Inc. (10.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.19M shares), STATE STREET CORP (5.18M shares), JPMORGAN CHASE & CO (4.33M shares), Boston Partners (3.04M shares), GEODE CAPITAL MANAGEMENT, LLC (2.98M shares), VICTORY CAPITAL MANAGEMENT INC (2.81M shares), MORGAN STANLEY (2.15M shares), and DIMENSIONAL FUND ADVISORS LP (1.9M shares).
This table shows the top 980 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.